Guo-bing Xiong

Publications (2)0 Total impact

• Article: [Dissection of prostate coalesce in treatment of benign prostate hypertrophy with relatively small volume].

  Ming-xing Qiu, Dong Wang, Hui-min Wu, Guo-bing Xiong, Zhao-xiang Chen
  [show abstract] [hide abstract]
  ABSTRACT: To evaluate the curative effect of dissection for coalesce of prostate in treatment of bladder outlet obstruction (BOO) caused by benign prostate hypertrophy (BPH) with relatively small volume (less than 30 g). Thirty-six patients of BOO caused by BPH with relatively small volume underwent dissection of prostate coalesce. Follow-up was conducted for 32 months (9 - 52 months). The values of international prostate symptom score (IPSS), maximum flow rate (Qmax), and postvoid residual volume (PRV) before and after treatment were measured and compared. The post-operative IPSS was 5.03 +/- 2.66, significantly lower than that before operation (14.19 +/- 5.35), the post-operative Qmax was (17.71 +/- 4.1) ml/s, significantly higher than that before operation [(6.19 +/- 2.14) ml/s], and the post-operative PRV was (8.53 +/- 4.78) ml, significantly lower than that before operation [(50.58 +/- 14.84) ml] (all P < 0.001). Dissection of prostate coalesce is an ideal method in treatment of BOO caused by BPH with relatively small volume (less than 30 g).
  Zhonghua yi xue za zhi 07/2007; 87(26):1852-3.
• Article: [Qingrelishi-category Chinese medicine for chronic prostatitis: a systematic review].

  Ming-xing Qiu, Guo-bing Xiong, Shi-yi Zhou, Dong Wang, Ji-chun Shao, Jiu-yuan Wang
  [show abstract] [hide abstract]
  ABSTRACT: To evaluate the efficacy and safety of the Qingrelishi-category Chinese medicine (for dispelling heat and resolving dampness) in the treatment of chronic prostatitis. Randomized clinical trials or controlled clinical trials comparing Qingrelishi with plant america, other herbal medicine and Western medicine in the treatment of chronic prostatitis were identified by electronic and manual retrieval and analysis. The methodological quality of the included trials was assessed and Meta-analysis was performed with Revman 4. 2 software. Forty-four randomized clinical trials or controlled clinical trials (n=5746) were identified. The methodological quality ranked high in three double-blind trials and the others ranked low. Meta-analysis indicated that Qingrelishi was more effective than Nankangpian( RR 1.22, 95% CI 1.10-1.35) and Prostate( RR 1.26, 95% CI 1.13-1.41) in the treatment of chronic prostatitis. Subgroup analysis revealed that Qingrelishi was more effective than Qianliekang (RR 1.32, 95% CI 1.19-1.45) and quinolones antibiotic (RR 1.34, 95% CI 1.15-1.57). There were no significant differences in efficacy either between Qingrelishi and a-receptor blocker and Puleanpian or between Qingrelishi plus quinolone antibiotics and quinolone antibiotics alone. Eighteen articles reported side effects and no serious adverse events were reported. Qingrelishi may be effective in the treatment of chronic prostatitis. However, the evidence is not strong due to the generally low methodological quality and the variations of the herbs. More randomized clinical trials are required.
  Zhonghua nan ke xue = National journal of andrology 05/2007; 13(4):370-7.